Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-Flow cytometry and mathematical modeling

Vaccine

Volumn 27, Issue 20, 2009, Pages 2712-2722

  Schulze Horsel, J ^a   Schulze, M ^b   Agalaridis, G ^c   Genzel, Y ^a   Reichl, U ^a,d  

^a MAX PLANCK INSTITUTE FOR DYNAMICS OF COMPLEX TECHNICAL SYSTEMS   (Germany)

^b TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

^c UNIVERSITY OF APPLIED SCIENCES   (Germany)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Apoptosis; Flow cytometry; Influenza vaccine production; Mathematical modeling; MDCK; Puerto Rico; Virus host cell interaction; Wisconsin

Indexed keywords

INFLUENZA VACCINE; VIRUS HEMAGGLUTININ;

ADHERENT CELL; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL POPULATION; CELL STRAIN; FLOW CYTOMETRY; INFLUENZA; INFLUENZA VIRUS A; MATHEMATICAL MODEL; MICROCARRIER CULTURE; NONHUMAN; PRIORITY JOURNAL; VACCINE PRODUCTION; VIRION; VIRUS PARTICLE; VIRUS STRAIN;

ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; DOGS; FLOW CYTOMETRY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; MODELS, THEORETICAL;

EID: 64449088759     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.02.027     Document Type: Article

References (56)

1. Tree J.A., Richardson C., Fooks A.R., Clegg J.C., and Looby D. Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. Vaccine 19 25-26 (2001) 3444-3450
2. Kemble G., and Greenberg H. Novel generations of influenza vaccines. Vaccine 21 16 (2003) 1789-1795
3. Merten O.W., Hannoun C., Manuguerra J.C., Ventre F., and Petres S. Production of influenza virus in cell cultures for vaccine preparation. Adv Exp Med Biol (1996) 141-151
4. Kistner O., Barrett P.N., Mundt W., Reiter M., Schober-Bendixen S., and Dorner F. Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. Vaccine 16 9-10 (1998) 960-968
5. Genzel Y., Behrendt I., Koenig S., Sann H., and Reichl U. Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture. Vaccine 22 June (17-18) (2004) 2202-2208
6. Pau M.G., Ophorst C., Koldijk M.H., Schouten G., Mehtali M., and Uytdehaag F. The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. Vaccine 19 17-19 (2001) 2716-2721
7. Sandig V, Jordan I, inventors. Immortalized avian cell lines for virus production. Germany; 2005 [30.11.2004].
8. Govorkova. African Green Monkey Kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses. J Virol 1996, 5519-24.
9. Gerdil C. The annual production cycle for influenza vaccine. Vaccine 21 May (16) (2003) 1776-1779
10. Lamb R.A., and Krug R.M. Orthomyxoviridae: the viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Fields virology. 4th ed. (2001), Lippincott Williams & Wilkins
11. Krug M. The influenza viruses (1989), Plenum Press, New York, London
12. Sidorenko Y., Schulze-Horsel J., Voigt A., Reichl U., and Kienle A. Stochastic population balance modeling of influenza virus replication in vaccine production processes. Chem Eng Sci 63 (2008) 157-169
13. Lonsdale R., Pau M.G., Oerlemans M., Ophorst C., Vooys A., Havenga M., et al. A rapid method for immunotitration of influenza viruses using flow cytometry. J Virol Methods 110 June (1) (2003) 67-71
14. Schulze-Horsel J., Genzel Y., and Reichl U. Flow cytometric monitoring of influenza A virus infection in MDCK cells during vaccine production. BMC Biotechnol 8 (2008) 45
15. Singh R., and Al-Rubeai M. Apoptosis and bioprocess technology. In: Scheper T. (Ed). Advances in biochemical engineering/biotechnology (1998), Springer 167-184
16. Kerr J.F.R., Wyllie A.H., and Currie A.R. Apoptosis-basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26 4 (1972) 239-257
17. Lawen A. Apoptosis-an introduction. Bioessays 25 Sep (9) (2003) 888-896
18. Frisch S.M., and Screaton R.A. Anoikis mechanisms. Curr Opin Cell Biol 13 Oct (5) (2001) 555-562
19. Arden N., and Betenbaugh M.J. Life and death in mammalian cell culture: strategies for apoptosis inhibition. Trends Biotechnol 22 Apr (4) (2004) 174-180
20. Mastrangelo A.J., and Betenbaugh M.J. Overcoming apoptosis: new methods for improving protein-expression systems. Trends Biotechnol 16 Feb (2) (1998) 88-95
21. Figueroa B., Ailor E., Osborne D., Hardwick J.M., Reff M., and Betenbaugh M.J. Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells. Biotechnol Bioeng 97 July (4) (2007) 877-892
22. Al-Rubeai M., and Singh R.P. Apoptosis in cell culture. Curr Opin Biotechnol 9 Apr (2) (1998) 152-156
23. Chaibi C., Cotte-Laffitte J., Sandre C., Esclatine A., Servin A.L., Quero A.M., et al. Rotavirus induces apoptosis in fully differentiated human intestinal Caco-2 cells. Virology 332 Feb (2) (2005) 480-490
24. Takizawa T., Matsukawa S., Higuchi Y., Nakamura S., Nakanishi Y., and Fukuda R. Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J Gen Virol 74 Nov (Pt 11) (1993) 2347-2355
25. Ludwig S., Planz O., Pleschka S., and Wolff T. Influenza-virus-induced signaling cascades: targets for antiviral therapy?. Trends Mol Med 9 2 (2003) 46-52
26. Ludwig S., Pleschka S., and Wolff T. A fatal relationship-influenza virus interactions with the host cell. Viral Immunol 12 3 (1999) 175-196
27. Geiss G.K., An M.C., Bumgarner R.E., Hammersmark E., Cunningham D., and Katze M.G. Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events. J Virol 75 May (9) (2001) 4321-4331
28. Wurzer W.J., Planz O., Ehrhardt C., Giner M., Silberzahn T., Pleschka S., et al. Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J 22 June (11) (2003) 2717-2728
29. Lin C., Holland R.E., Donofrio J.C., McCoy M.H., Tudor L.R., and Chambers T.M. Caspase activation in equine influenza virus induced apoptotic cell death. Vet Microbiol 84 Feb (4) (2002) 357-365
30. Lin C., Zimmer S.G., Lu Z., Holland R.E., Dong Q., and Chambers T.M. The involvement of a stress-activated pathway in equine influenza virus-mediated apoptosis. Virology 287 Aug (1) (2001) 202-213
31. Takizawa T., Tatematsu C., Ohashi K., and Nakanishi Y. Recruitment of apoptotic cysteine proteases (caspases) in influenza virus-induced cell death. Microbiol Immunol 43 3 (1999) 245-252
32. Zhirnov O.P., Konakova T.E., Garten W., and Klenk H.D. Caspase-dependent N-terminal cleavage of influenza virus nucleocapsid protein in infected cells. J Virol 73 Dec (12) (1999) 10158-10163
33. Kurokawa M., Koyama A.H., Yasuoka S., and Adachi A. Influenza virus overcomes apoptosis by rapid multiplication. Int J Mol Med 3 5 (1999) 527-530
34. Hornickova Z. Different progress of MDCK cell death after infection by two different influenza virus isolates. Cell Biochem Funct 15 2 (1997) 87-93
35. Mersich S.E., Baumeister E.G., Riva D., Lewis A.P., Cadario M.E., Pontoriero A.V., et al. Influenza circulating strains in Argentina exhibit differential induction of cytotoxicity and caspase-3 in vitro. J Clin Virol 31 Oct (2) (2004) 134-139
36. Mohsin M.A., Morris S.J., Smith H., and Sweet C. Correlation between levels of apoptosis, levels of infection and haemagglutinin receptor binding interaction of various subtypes of influenza virus: does the viral neuraminidase have a role in these associations. Virus Res 85 2 (2002) 123-131
37. Wu H.L., Huang Y.X., Dykes C., Liu D.C., Ma J.M., Perelson A.S., et al. Modeling and estimation of replication fitness of human immunodeficiency virus type 1 in vitro experiments by using a growth competition assay. J Virol 80 March (5) (2006) 2380-2389
38. Miao H.Y., Dykes C., Demeter L.M., Cavenaugh J., Park S.Y., Perelson A.S., et al. Modeling and estimation of kinetic parameters and replicative fitness of HIV-1 from flow-cytometry-based growth competition experiments. Bull Math Biol 70 Aug (6) (2008) 1749-1771
39. Dixit N.M., and Perelson A.S. Multiplicity of human immunodeficiency virus infections in lymphoid tissue. J Virol 78 Aug (16) (2004) 8942-8945
40. Dixit N.M., and Perelson A.S. HIV dynamics with multiple infections of target cells. Proc Natl Acad Sci U S A 102 June (23) (2005) 8198-8203
41. Sidorenko Y., Voigt A., Schulze-Horsel J., Reichl U., and Kienle A. Stochastic population balance modeling of influenza virus replication in vaccine production processes. II. Detailed description of the replication mechanism. Chem Eng Sci 63 Apr (8) (2008) 2299-2304
42. Müller T., Schulze-Horsel J., Sidorenko Y., Reichl U., and Kienle A. Population balance modeling of influenza virus replication in MDCK cells during vaccine production. In: Braunschweig B., and Joulia X. (Eds). Computer-Aided Chemical Engineering 25: 18th European Symposium On Computer Aided Process Engineering (2008), Elsevier 133-138
43. Genzel Y., Behrendt I., König S., Sann H., and Reichl U. Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture. Vaccine 22 (2004) 2202-2208
44. Bock A, Moehler L, Sann H, Schulze-Horsel J, Genzel Y, Reichl U. Growth behaviour of number distributed adherent MDCK cells for optimization in large scale microcarrier cultures, submitted for publication.
45. Kalbfuss B., Knoechlein A., Kroeber T., and Reichl U. Monitoring influenza virus content in vaccine production: precise assays for the quantitation of hemagglutination and neuraminidase activity. Biologicals 36 3 (2008) 145-161
46. Burleson F.G., Wiedbrauk C.T.M., and Virology D.L. A laboratory manual (1992), Academic Press
47. Mahy B., and Kangro H. Virology methods manual (1996), Academic Press
48. Genzel Y., Fischer M., and Reichl U. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture. Vaccine 24 Apr (16) (2006) 3261-3272
49. Gaush C.R., and Smith T.F. Replication and plaque assay of influenza virus in an established line of canine kidney cells. Appl Microbiol 16 Apr (4) (1968) 588-594
50. Schultz-Cherry S., and Hinshaw V.S. Influenza virus neuraminidase activates latent transforming growth factor beta. J Virol 70 Dec (12) (1996) 8624-8629
51. Ludwig S., Pleschka S., Planz O., and Wolff T. Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells. Cell Microbiol 8 Mar (3) (2006) 375-386
52. Rosenblatt J., Raff M.C., and Cramer L.P. An epithelial cell destined for apoptosis signals its neighbors to extrude it by an actin- and myosin-dependent mechanism. Curr Biol 11 Nov (23) (2001) 1847-1857
53. Möhler L., Flockerzi D., Sann H., and Reichl U. Mathematical model of influenza A virus production in large-scale microcarrier culture. Biotechnol Bioeng 90 1 (2005) 46-58
54. Ngunjiri J.M., Sekellick M.J., and Marcus P.I. Clonogenic assay of type a influenza viruses reveals noninfectious cell-killing (apoptosis-inducing) particles. J Virol 82 Mar (6) (2008) 2673-2680
55. Storn R., and Price K. Differential evolution-A simple and efficient heuristic for global optimization over continuous spaces. J Global Optim 11 Dec (4) (1997) 341-359
56. Horio M., Ito A., Matsuoka Y., Moriyama T., Orita Y., Takenaka M., et al. Apoptosis induced by hypertonicity in Madin Darley canine kidney cells: protective effect of betaine. Nephrol Dial Transplant 16 3 (2001) 483-490